#evaluate(de(' #AdditionalMetaTags# '))#
Venturelab
close

Restoring hip strength to resist breaking

flowbone SA

Swiss Startup - flowbone Profile Main Image
Incorporated
27.07.2020
Headquarters
Lausanne
Support

FLOWBONE is involved in the development and promotion of a revolutionary biomaterial for the minimal-invasive augmentation of fragile bones. FLOWBONE, follows a completely new treatment approach allowing fragilized bone to augment and repair itself without impeding bone mechanics or blood flow within the bone. The product can be used for both bone repair and fragility fracture prevention, and their initial focus will be targeting high risk areas such as the spine and hips. The technology is the result of 6+ years of research at EPFL is currently in the pre-clinical phase preparing for clinical trials prior to market commercialization.

News

06.09.2024

Kickfund invests at full throttle (startupticker.ch)

27.10.2022

Swiss startups take the lead on global stages (startupticker.ch)

01.09.2022

Ten startups to explore India (startupticker.ch)

24.06.2021

IMAGINE IF! Swiss winners revealed (startupticker.ch)

09.06.2021

First Venture Leaders Medtech selected (startupticker.ch)

12.05.2021

Finalists of the W. A de Vigier revealed (startupticker.ch)

06.05.2021

Flowbone triomphe aux Prix PERL 2021 (startupticker.ch)

Show all

Milestones news

25.02.2022

FDA regulatory strategy determined

31.12.2021

Scale-up of the production to kilo-batches

01.08.2021

Submission of pre-Request for Designation to FDA

30.06.2021

Signature of exclusive patent license agreement with EPFL

31.05.2021

Validated proof-of-concept in large animals

Show all
Swiss Startup - flowbone Product Image Swiss Startup - flowbone Team Image Swiss Startup - flowbone Additional Image

Videos and Presentations

flowbone: local bone strengthening to prevent devastating hip fractures

Pitch Startup Champions Seed Night 2020

Player is loading...